Nonergot Dopamine Agonist [EPC]

Nonergot Dopamine Agonist [EPC] was reported 15621 times

These side effects are most commonly reported by patients taking drugs of the Nonergot Dopamine Agonist [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 2361
1 FALL 2070
2 PRODUCT ADHESION ISSUE 1985
3 DEATH 1648
4 HALLUCINATION 1502
5 OFF LABEL USE 1498
6 NAUSEA 1459
7 FATIGUE 1430
8 DIZZINESS 1271
9 PARKINSON^S DISEASE 1191
10 DYSKINESIA 1185
11 TREMOR 1142
12 INSOMNIA 1001
13 SOMNOLENCE 996
14 GAIT DISTURBANCE 995
15 ASTHENIA 960
16 PAIN 960
17 DYSPNOEA 902
18 PNEUMONIA 853
19 MALAISE 839
20 CONDITION AGGRAVATED 829
21 HEADACHE 805
22 DIARRHOEA 804
23 VOMITING 802
24 ANXIETY 780
25 CONFUSIONAL STATE 750
26 WEIGHT DECREASED 742
27 PRODUCT DOSE OMISSION ISSUE 715
28 URINARY TRACT INFECTION 714
29 CONSTIPATION 678
30 RESTLESS LEGS SYNDROME 677
31 ON AND OFF PHENOMENON 665
32 FEELING ABNORMAL 614
33 DEPRESSION 593
34 MEMORY IMPAIRMENT 590
35 BALANCE DISORDER 589
36 PAIN IN EXTREMITY 574
37 OVERDOSE 550
38 ARTHRALGIA 539
39 MUSCLE SPASMS 516
40 MOBILITY DECREASED 496
41 COUGH 491
42 PRURITUS 488
43 HALLUCINATION, VISUAL 487
44 RASH 466
45 BACK PAIN 457
46 APPLICATION SITE ERYTHEMA 454
47 APPLICATION SITE PRURITUS 452
48 DYSPHAGIA 450
49 MUSCLE RIGIDITY 450
50 DECREASED APPETITE 448
51 CHRONIC KIDNEY DISEASE 444
52 HYPOTENSION 442
53 LOSS OF CONSCIOUSNESS 426
54 MUSCULOSKELETAL STIFFNESS 422
55 ACUTE KIDNEY INJURY 417
56 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 417
57 WEIGHT INCREASED 403
58 PERIPHERAL SWELLING 402
59 DEVICE ISSUE 401
60 DRUG INTERACTION 398
61 GENERAL PHYSICAL HEALTH DETERIORATION 396
62 RENAL FAILURE 388
63 HYPERHIDROSIS 383
64 FREEZING PHENOMENON 381
65 DEVICE ADHESION ISSUE 379
66 PYREXIA 377
67 SPEECH DISORDER 365
68 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 353
69 HOSPITALISATION 350
70 INCORRECT DOSE ADMINISTERED 349
71 HYPERTENSION 330
72 COVID-19 324
73 OEDEMA PERIPHERAL 324
74 THERAPY INTERRUPTED 321
75 MUSCULAR WEAKNESS 320
76 UNEVALUABLE EVENT 317
77 AGITATION 307
78 ABDOMINAL PAIN 305
79 PRODUCT USE ISSUE 305
80 DEHYDRATION 303
81 SLEEP DISORDER 299
82 BRADYKINESIA 294
83 HYPOAESTHESIA 292
84 COGNITIVE DISORDER 291
85 DELUSION 290
86 CEREBROVASCULAR ACCIDENT 282
87 SYNCOPE 282
88 PARAESTHESIA 280
89 GASTROOESOPHAGEAL REFLUX DISEASE 273
90 STOMA SITE DISCHARGE 273
91 INTENTIONAL PRODUCT MISUSE 272
92 CHEST PAIN 269
93 ERYTHEMA 267
94 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 265
95 ABDOMINAL PAIN UPPER 262
96 ANAEMIA 259
97 BLOOD PRESSURE INCREASED 256
98 DELIRIUM 251
99 PRODUCT QUALITY ISSUE 248
100 VISION BLURRED 245
101 PRODUCT USE IN UNAPPROVED INDICATION 244
102 SEIZURE 241
103 STRESS 241
104 DRY MOUTH 240
105 MYOCARDIAL INFARCTION 240
106 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 237
107 ABDOMINAL DISCOMFORT 236
108 ATRIAL FIBRILLATION 233
109 DYSTONIA 233
110 ABNORMAL DREAMS 232
111 MOVEMENT DISORDER 231
112 SEPSIS 228
113 CONTUSION 227
114 DEMENTIA 227
115 RESTLESSNESS 226
116 ASTHMA 225
117 DEVICE DISLOCATION 224
118 VISUAL IMPAIRMENT 224
119 APPLICATION SITE REACTION 222
120 AGGRESSION 221
121 THERAPEUTIC RESPONSE SHORTENED 220
122 DISTURBANCE IN ATTENTION 217
123 MYALGIA 217
124 ABNORMAL BEHAVIOUR 216
125 DEPRESSED MOOD 214
126 HYPERSENSITIVITY 213
127 DRUG HYPERSENSITIVITY 211
128 APPLICATION SITE RASH 207
129 INFECTION 206
130 STOMA SITE ERYTHEMA 206
131 HIP FRACTURE 202
132 NASOPHARYNGITIS 194
133 NIGHTMARE 194
134 PNEUMONIA ASPIRATION 193
135 DRUG DOSE OMISSION 192
136 DISORIENTATION 191
137 GAIT INABILITY 190
138 ALOPECIA 189
139 NEUROPATHY PERIPHERAL 185
140 PSYCHOTIC DISORDER 185
141 DEVICE OCCLUSION 183
142 POOR QUALITY SLEEP 182
143 ADVERSE DRUG REACTION 178
144 NOCTURIA 178
145 AMNESIA 173
146 COMPLETED SUICIDE 173
147 SUICIDAL IDEATION 173
148 DYSARTHRIA 171
149 ILLNESS 171
150 ABDOMINAL DISTENSION 169
151 HYPOKINESIA 164
152 INFLUENZA 164
153 MIDDLE INSOMNIA 164
154 PRODUCT AVAILABILITY ISSUE 163
155 BLOOD PRESSURE DECREASED 162
156 JOINT SWELLING 160
157 HEAD INJURY 159
158 HYPERSOMNIA 159
159 HYPERKINESIA 158
160 CARDIAC ARREST 157
161 DYSSTASIA 157
162 INJECTION SITE PAIN 157
163 PRODUCT DOSE OMISSION 155
164 IMPULSE-CONTROL DISORDER 153
165 DYSPHONIA 152
166 CARDIAC FAILURE 151
167 BLOOD GLUCOSE INCREASED 149
168 BRONCHITIS 147
169 CARDIAC FAILURE CONGESTIVE 147
170 DYSPEPSIA 147
171 UNDERDOSE 147
172 APHASIA 145
173 HAEMOGLOBIN DECREASED 144
174 CHILLS 142
175 HEART RATE INCREASED 141
176 STOMA SITE PAIN 140
177 IRRITABILITY 139
178 CHEST DISCOMFORT 136
179 CHOKING 136
180 ORTHOSTATIC HYPOTENSION 136
181 SINUSITIS 136
182 CARDIAC DISORDER 135
183 PALPITATIONS 135
184 PHARMACEUTICAL PRODUCT COMPLAINT 135
185 THERAPEUTIC PRODUCT EFFECT DECREASED 134
186 ARTHRITIS 133
187 GASTROINTESTINAL HAEMORRHAGE 132
188 SWELLING 132
189 TACHYCARDIA 131
190 TREATMENT NONCOMPLIANCE 131
191 URTICARIA 131
192 HYPERSEXUALITY 129
193 HYPOPHAGIA 129
194 DRUG INTOLERANCE 128
195 SURGERY 128
196 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 127
197 THERAPEUTIC RESPONSE UNEXPECTED 127
198 PARKINSONISM 125
199 CATARACT 124
200 APPLICATION SITE IRRITATION 123
201 UNRESPONSIVE TO STIMULI 123
202 DRUG WITHDRAWAL SYNDROME 122
203 RESPIRATORY FAILURE 122
204 CARDIO-RESPIRATORY ARREST 119
205 NASAL CONGESTION 119
206 THERAPY CESSATION 119
207 NERVOUSNESS 118
208 WITHDRAWAL SYNDROME 118
209 URINARY INCONTINENCE 117
210 MIGRAINE 116
211 ADVERSE EVENT 114
212 FEELING HOT 114
213 OXYGEN SATURATION DECREASED 114
214 BURNING SENSATION 113
215 THERAPEUTIC PRODUCT EFFECT VARIABLE 113
216 THROMBOSIS 113
217 FLUID RETENTION 112
218 LIMB DISCOMFORT 112
219 BLISTER 111
220 SLEEP APNOEA SYNDROME 111
221 TRANSIENT ISCHAEMIC ATTACK 111
222 EMOTIONAL DISTRESS 110
223 RENAL IMPAIRMENT 110
224 END STAGE RENAL DISEASE 109
225 FLUSHING 109
226 PLATELET COUNT DECREASED 109
227 RIB FRACTURE 109
228 SEROTONIN SYNDROME 109
229 SKIN IRRITATION 109
230 TOXICITY TO VARIOUS AGENTS 109
231 HOT FLUSH 108
232 INITIAL INSOMNIA 108
233 COMPULSIVE SHOPPING 107
234 PULMONARY EMBOLISM 107
235 DRUG EFFECT DECREASED 106
236 MENTAL DISORDER 105
237 TENSION 105
238 INTENTIONAL PRODUCT USE ISSUE 104
239 PANIC ATTACK 104
240 GASTROINTESTINAL DISORDER 103
241 INTESTINAL OBSTRUCTION 103
242 TYPE 2 DIABETES MELLITUS 103
243 VERTIGO 103
244 WHITE BLOOD CELL COUNT DECREASED 102
245 CELLULITIS 101
246 DISCOMFORT 101
247 HYPERGLYCAEMIA 101
248 LETHARGY 101
249 PARANOIA 101
250 RESPIRATORY ARREST 101
251 DISEASE PROGRESSION 100
252 NECK PAIN 100
253 DEVICE DIFFICULT TO USE 99
254 NEUROLEPTIC MALIGNANT SYNDROME 99
255 CYSTITIS 98
256 NO ADVERSE EVENT 98
257 HAEMORRHAGE 97
258 MULTIPLE SCLEROSIS RELAPSE 97
259 OSTEOARTHRITIS 97
260 BLOOD PRESSURE FLUCTUATION 96
261 FEMUR FRACTURE 96
262 OBSESSIVE-COMPULSIVE DISORDER 96
263 POLLAKIURIA 96
264 EPILEPSY 95
265 OROPHARYNGEAL PAIN 95
266 ROAD TRAFFIC ACCIDENT 95
267 DIABETES MELLITUS 94
268 REDUCED FACIAL EXPRESSION 94
269 SUICIDE ATTEMPT 94
270 DOPAMINE DYSREGULATION SYNDROME 93
271 HALLUCINATION, AUDITORY 93
272 MEDICATION ERROR 93
273 MENTAL STATUS CHANGES 93
274 PSORIASIS 93
275 BEDRIDDEN 92
276 DEVICE BREAKAGE 92
277 DIPLOPIA 92
278 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 92
279 APPLICATION SITE VESICLES 91
280 DERMATITIS CONTACT 91
281 NEPHROLITHIASIS 90
282 PARKINSON'S DISEASE 90
283 PRESCRIBED UNDERDOSE 90
284 DEVICE LEAKAGE 89
285 DRUG EFFECT INCOMPLETE 89
286 GAMBLING DISORDER 89
287 PLEURAL EFFUSION 89
288 RHINORRHOEA 89
289 AKINESIA 88
290 APPLICATION SITE PAIN 88
291 INJURY 87
292 INTENTIONAL OVERDOSE 87
293 MENTAL IMPAIRMENT 87
294 DEPRESSED LEVEL OF CONSCIOUSNESS 86
295 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 86
296 OSTEOPOROSIS 86
297 PRODUCTIVE COUGH 86
298 PSYCHOMOTOR HYPERACTIVITY 86
299 RENAL INJURY 86
300 POSTURE ABNORMAL 85
301 STOMA SITE INFECTION 85
302 FLATULENCE 84
303 HYPONATRAEMIA 83
304 ILL-DEFINED DISORDER 83
305 MOTOR DYSFUNCTION 83
306 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 82
307 MUSCLE TWITCHING 81
308 STOMA SITE REACTION 81
309 URINARY RETENTION 81
310 INJECTION SITE ERYTHEMA 80
311 MICTURITION URGENCY 80
312 EATING DISORDER 79
313 EPISTAXIS 79
314 RHEUMATOID ARTHRITIS 79
315 THROMBOCYTOPENIA 79
316 OEDEMA 78
317 FEEDING DISORDER 77
318 NEPHROGENIC ANAEMIA 77
319 SALIVARY HYPERSECRETION 77
320 ANOSMIA 76
321 RHABDOMYOLYSIS 76
322 BLOOD CREATININE INCREASED 75
323 DRY SKIN 75
324 DYSPNOEA EXERTIONAL 75
325 HERPES ZOSTER 75
326 STAPHYLOCOCCAL INFECTION 75
327 AGEUSIA 74
328 IMPAIRED GASTRIC EMPTYING 74
329 MOOD ALTERED 74
330 ARRHYTHMIA 73
331 ARTHROPATHY 73
332 FEAR 73
333 LIMB INJURY 73
334 MULTIPLE SCLEROSIS 73
335 SPINAL OPERATION 73
336 THERAPY NON-RESPONDER 73
337 DROOLING 72
338 DYSGEUSIA 72
339 FULL BLOOD COUNT ABNORMAL 72
340 HAEMATOCHEZIA 72
341 SKIN EXFOLIATION 72
342 UPPER LIMB FRACTURE 72
343 CRYING 71
344 DEVICE MALFUNCTION 71
345 DRUG ABUSE 71
346 NEUTROPENIA 71
347 PRESCRIBED OVERDOSE 71
348 RECTAL HAEMORRHAGE 71
349 THERAPEUTIC RESPONSE DECREASED 71
350 INFLUENZA LIKE ILLNESS 70
351 INTENTIONAL DOSE OMISSION 70
352 DEVICE USE ISSUE 69
353 DYSURIA 69
354 EXTRA DOSE ADMINISTERED 69
355 NEOPLASM MALIGNANT 69
356 ASPIRATION 68
357 BEHAVIOUR DISORDER 68
358 DECUBITUS ULCER 68
359 RENAL DISORDER 68
360 STOMA SITE HAEMORRHAGE 68
361 STOMA SITE INFLAMMATION 68
362 UPPER RESPIRATORY TRACT INFECTION 68
363 COMA 67
364 HEART RATE DECREASED 67
365 PRODUCT PHYSICAL ISSUE 67
366 PRODUCT SUBSTITUTION ISSUE 67
367 INCONTINENCE 66
368 PULMONARY OEDEMA 66
369 SEDATION 66
370 SKIN DISCOLOURATION 66
371 WHEEZING 66
372 BRADYCARDIA 65
373 DEEP VEIN THROMBOSIS 65
374 EMOTIONAL DISORDER 65
375 LOCALISED INFECTION 65
376 MUSCULOSKELETAL DISORDER 65
377 ANGER 64
378 BLOOD POTASSIUM DECREASED 64
379 HOSPICE CARE 64
380 REHABILITATION THERAPY 64
381 TARDIVE DYSKINESIA 64
382 BONE PAIN 63
383 ALTERED STATE OF CONSCIOUSNESS 62
384 APATHY 62
385 INFUSION SITE ERYTHEMA 62
386 PARALYSIS 62
387 SKIN LESION 62
388 STOMA SITE HYPERGRANULATION 62
389 WOUND 62
390 C-REACTIVE PROTEIN INCREASED 61
391 CEREBRAL HAEMORRHAGE 61
392 HYPOKALAEMIA 61
393 HYPOXIA 61
394 PRODUCT DOSE OMISSION IN ERROR 61
395 PRODUCT RESIDUE PRESENT 61
396 HYPOACUSIS 60
397 IMPULSIVE BEHAVIOUR 60
398 INFLAMMATION 60
399 INJECTION SITE BRUISING 60
400 FIBROMA 59
401 MUSCULOSKELETAL PAIN 59
402 ACUTE RESPIRATORY FAILURE 58
403 IMPAIRED QUALITY OF LIFE 58
404 INABILITY TO AFFORD MEDICATION 58
405 INFUSION SITE INDURATION 58
406 INTERVERTEBRAL DISC PROTRUSION 58
407 KNEE ARTHROPLASTY 58
408 NEURALGIA 58
409 SENSORY DISTURBANCE 58
410 DEEP BRAIN STIMULATION 57
411 JOINT INJURY 57
412 STOMATITIS 57
413 SWELLING FACE 57
414 GAMBLING 56
415 GASTRITIS 56
416 NONSPECIFIC REACTION 56
417 POST PROCEDURAL COMPLICATION 56
418 PRODUCT PRESCRIBING ERROR 56
419 RASH PRURITIC 56
420 RESPIRATORY TRACT INFECTION 56
421 SUDDEN ONSET OF SLEEP 56
422 APPLICATION SITE SWELLING 55
423 FLUID INTAKE REDUCED 55
424 KIDNEY INFECTION 55
425 RETCHING 55
426 WRONG TECHNIQUE IN DRUG USAGE PROCESS 55
427 DRY EYE 54
428 EYE PAIN 54
429 FRACTURE 54
430 HAEMATURIA 54
431 MANIA 54
432 THINKING ABNORMAL 54
433 ERECTILE DYSFUNCTION 53
434 PATHOLOGICAL GAMBLING 53
435 RASH MACULAR 53
436 SKIN ULCER 53
437 SLEEP TALKING 53
438 SWOLLEN TONGUE 53
439 THROAT IRRITATION 53
440 WHITE BLOOD CELL COUNT INCREASED 53
441 ACUTE MYOCARDIAL INFARCTION 52
442 ANAL INCONTINENCE 52
443 DEVICE KINK 52
444 DRUG DEPENDENCE 52
445 HEAD DISCOMFORT 52
446 HYPERKALAEMIA 52
447 INFUSION RELATED REACTION 52
448 ABNORMAL FAECES 51
449 BOWEL MOVEMENT IRREGULARITY 51
450 ECONOMIC PROBLEM 51
451 FOOT DEFORMITY 51
452 FOOT FRACTURE 51
453 HALLUCINATIONS, MIXED 51
454 HYPOGLYCAEMIA 51
455 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 51
456 INFUSION SITE PAIN 51
457 LIBIDO INCREASED 51
458 LUNG DISORDER 51
459 REBOUND ACID HYPERSECRETION 51
460 RESTLESS LEG AUGMENTATION SYNDROME 51
461 SKIN LACERATION 51
462 ABASIA 50
463 BLOOD CREATINE PHOSPHOKINASE INCREASED 50
464 MOOD SWINGS 50
465 NIGHT SWEATS 50
466 RED BLOOD CELL COUNT DECREASED 50
467 BACK DISORDER 49
468 BLOOD PRESSURE ABNORMAL 49
469 INSURANCE ISSUE 49
470 RESPIRATORY DISTRESS 49
471 SKIN CANCER 49
472 CHOLELITHIASIS 48
473 FUNGAL INFECTION 48
474 HAEMOPTYSIS 48
475 LOWER LIMB FRACTURE 48
476 LOWER RESPIRATORY TRACT INFECTION 48
477 PALLOR 48
478 SKIN REACTION 48
479 SPINAL FRACTURE 48
480 ANHEDONIA 47
481 CARDIOVASCULAR DISORDER 47
482 FIBROMYALGIA 47
483 GASTROINTESTINAL MOTILITY DISORDER 47
484 HAEMORRHOIDS 47
485 HEART RATE IRREGULAR 47
486 LIP SWELLING 47
487 PANCYTOPENIA 47
488 PRODUCT DISPENSING ISSUE 47
489 WALKING AID USER 47
490 ANKLE FRACTURE 46
491 DECREASED INTEREST 46
492 EYE IRRITATION 46
493 ILEUS 46
494 INCREASED APPETITE 46
495 LIGAMENT SPRAIN 46
496 RESPIRATORY DISORDER 46
497 WRIST FRACTURE 46
498 BLINDNESS 45
499 COORDINATION ABNORMAL 45
500 EXPIRED PRODUCT ADMINISTERED 45
501 INJECTION SITE HAEMORRHAGE 45
502 INTERVERTEBRAL DISC DEGENERATION 45
503 MELAENA 45
504 PARKINSONIAN GAIT 45
505 PRODUCT STORAGE ERROR 45
506 PSYCHIATRIC SYMPTOM 45
507 SOMNAMBULISM 45
508 TINNITUS 45
509 BLOOD GLUCOSE DECREASED 44
510 CARPAL TUNNEL SYNDROME 44
511 DIVERTICULITIS 44
512 ENCEPHALOPATHY 44
513 GLAUCOMA 44
514 PRESYNCOPE 44
515 RENAL FAILURE ACUTE 44
516 SKIN DISORDER 44
517 THERAPEUTIC PRODUCT EFFECT DELAYED 44
518 BLOOD IRON DECREASED 43
519 COMPULSIONS 43
520 DISEASE RECURRENCE 43
521 FEELING JITTERY 43
522 HAEMATOCRIT DECREASED 43
523 HERNIA 43
524 HIP SURGERY 43
525 NERVOUS SYSTEM DISORDER 43
526 PANCREATITIS 43
527 STEREOTYPY 43
528 FEELING COLD 42
529 HAEMATEMESIS 42
530 HIP ARTHROPLASTY 42
531 INJECTION SITE REACTION 42
532 KNEE OPERATION 42
533 LEUKOCYTOSIS 42
534 SEXUAL DYSFUNCTION 42
535 SLEEP ATTACKS 42
536 STOMA SITE EXTRAVASATION 42
537 STOMA SITE IRRITATION 42
538 YAWNING 42
539 COVID-19 PNEUMONIA 41
540 DRUG EFFECT LESS THAN EXPECTED 41
541 EXTRAPYRAMIDAL DISORDER 41
542 JOINT DISLOCATION 41
543 NEUTROPHIL COUNT INCREASED 41
544 PRODUCT DISPENSING ERROR 41
545 TUBULOINTERSTITIAL NEPHRITIS 41
546 CONVULSION 40
547 CROHN^S DISEASE 40
548 DROPPED HEAD SYNDROME 40
549 EYE DISORDER 40
550 HAEMATOMA 40
551 LOGORRHOEA 40
552 POLYNEUROPATHY 40
553 PRODUCT ADMINISTRATION ERROR 40
554 PRODUCT PRESCRIBING ISSUE 40
555 DERMATITIS ALLERGIC 39
556 DIZZINESS POSTURAL 39
557 HEPATIC ENZYME INCREASED 39
558 INCORRECT DOSE ADMINISTERED BY DEVICE 39
559 INTERNAL HAEMORRHAGE 39
560 JOINT STIFFNESS 39
561 LABORATORY TEST ABNORMAL 39
562 MUSCLE SPASTICITY 39
563 SINUS DISORDER 39
564 APPLICATION SITE HYPERSENSITIVITY 38
565 ASPARTATE AMINOTRANSFERASE INCREASED 38
566 CLOSTRIDIUM DIFFICILE INFECTION 38
567 COMPLICATION ASSOCIATED WITH DEVICE 38
568 DECREASED ACTIVITY 38
569 EMBEDDED DEVICE 38
570 GOUT 38
571 IMMOBILE 38
572 INJECTION SITE PRURITUS 38
573 INJECTION SITE SWELLING 38
574 PARKINSON^S DISEASE PSYCHOSIS 38
575 SCIATICA 38
576 SKIN ABRASION 38
577 SKIN BURNING SENSATION 38
578 ALANINE AMINOTRANSFERASE INCREASED 37
579 BLOOD URINE PRESENT 37
580 DEVICE CONNECTION ISSUE 37
581 DRUG ADMINISTRATION ERROR 37
582 LIBIDO DECREASED 37
583 OCULAR HYPERAEMIA 37
584 OSTEOMYELITIS 37
585 RASH ERYTHEMATOUS 37
586 ROTATOR CUFF SYNDROME 37
587 SLUGGISHNESS 37
588 TOOTH DISORDER 37
589 ACCIDENTAL EXPOSURE TO PRODUCT 36
590 BIPOLAR DISORDER 36
591 BLOOD ALKALINE PHOSPHATASE INCREASED 36
592 BLOOD CHOLESTEROL INCREASED 36
593 CHROMATURIA 36
594 DEMENTIA ALZHEIMER^S TYPE 36
595 LACRIMATION INCREASED 36
596 PERITONITIS 36
597 PROSTATE CANCER 36
598 SPINAL COMPRESSION FRACTURE 36
599 UPPER GASTROINTESTINAL HAEMORRHAGE 36
600 BLADDER DISORDER 35
601 BLOOD COUNT ABNORMAL 35
602 BLOOD SODIUM DECREASED 35
603 COLD SWEAT 35
604 DYSCHEZIA 35
605 FAECES HARD 35
606 HEPATIC STEATOSIS 35
607 IMPAIRED HEALING 35
608 INFUSION SITE SWELLING 35
609 LYMPHOCYTE COUNT DECREASED 35
610 MUSCLE TIGHTNESS 35
611 ORAL PAIN 35
612 OSTEOPENIA 35
613 PERIPHERAL COLDNESS 35
614 PERSECUTORY DELUSION 35
615 PROCEDURAL PAIN 35
616 PSORIATIC ARTHROPATHY 35
617 SCREAMING 35
618 SPINAL OSTEOARTHRITIS 35
619 VIRAL INFECTION 35
620 ANGINA PECTORIS 34
621 BRAIN FOG 34
622 CEREBRAL INFARCTION 34
623 DEVICE USE ERROR 34
624 INCOHERENT 34
625 INFUSION SITE REACTION 34
626 LOCAL SWELLING 34
627 ACUTE PSYCHOSIS 33
628 APPLICATION SITE DISCOLOURATION 33
629 BLADDER CANCER 33
630 BODY HEIGHT DECREASED 33
631 COLITIS 33
632 CORONARY ARTERY DISEASE 33
633 DEVICE LOOSENING 33
634 ENERGY INCREASED 33
635 FINE MOTOR SKILL DYSFUNCTION 33
636 GASTRIC ULCER 33
637 HAND FRACTURE 33
638 HICCUPS 33
639 HYPERPARATHYROIDISM SECONDARY 33
640 LUNG NEOPLASM MALIGNANT 33
641 POLYP 33
642 QUALITY OF LIFE DECREASED 33
643 SECRETION DISCHARGE 33
644 SEPTIC SHOCK 33
645 SPINAL STENOSIS 33
646 TOXIC ENCEPHALOPATHY 33
647 WEIGHT FLUCTUATION 33
648 WHEELCHAIR USER 33
649 BREAST CANCER 32
650 DRUG DISPENSING ERROR 32
651 ECZEMA 32
652 FEELING DRUNK 32
653 GASTRIC DISORDER 32
654 GLOMERULAR FILTRATION RATE DECREASED 32
655 INCORRECT PRODUCT ADMINISTRATION DURATION 32
656 LEUKOPENIA 32
657 METABOLIC ACIDOSIS 32
658 PERICARDIAL EFFUSION 32
659 PRODUCT USE COMPLAINT 32
660 ACTIVITIES OF DAILY LIVING IMPAIRED 31
661 CONTRAINDICATED PRODUCT ADMINISTERED 31
662 EUPHORIC MOOD 31
663 HYPOMANIA 31
664 INFARCTION 31
665 INJECTION SITE MASS 31
666 LACERATION 31
667 PARKINSONISM HYPERPYREXIA SYNDROME 31
668 PRODUCT ADMINISTRATION INTERRUPTED 31
669 PULMONARY HYPERTENSION 31
670 SENSORY LOSS 31
671 TERMINAL STATE 31
672 ACCIDENT 30
673 ACCIDENTAL OVERDOSE 30
674 ANGIOEDEMA 30
675 APPLICATION SITE URTICARIA 30
676 CANDIDA INFECTION 30
677 CIRCULATORY COLLAPSE 30
678 FEMORAL NECK FRACTURE 30
679 HIATUS HERNIA 30
680 INFREQUENT BOWEL MOVEMENTS 30
681 INTENTIONAL UNDERDOSE 30
682 JEALOUS DELUSION 30
683 LIVER DISORDER 30
684 MALNUTRITION 30
685 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 30
686 PRODUCT DISTRIBUTION ISSUE 30
687 RASH GENERALISED 30
688 THERAPEUTIC PRODUCT INEFFECTIVE 30
689 THERMAL BURN 30
690 DEVICE ALARM ISSUE 29
691 DEVICE PHYSICAL PROPERTY ISSUE 29
692 DEVICE RELATED INFECTION 29
693 DISABILITY 29
694 GALLBLADDER DISORDER 29
695 HEPATIC FUNCTION ABNORMAL 29
696 HYPOCALCAEMIA 29
697 HYPOTHYROIDISM 29
698 IMMUNODEFICIENCY 29
699 IMPAIRED DRIVING ABILITY 29
700 INGUINAL HERNIA 29
701 MALIGNANT MELANOMA 29
702 PANCREATITIS ACUTE 29
703 SEASONAL ALLERGY 29
704 SPUTUM DISCOLOURED 29
705 TOOTH FRACTURE 29
706 ULCER 29
707 ANAPHYLACTIC REACTION 28
708 ATAXIA 28
709 DEPENDENCE 28
710 FAECES DISCOLOURED 28
711 FREQUENT BOWEL MOVEMENTS 28
712 GENERALISED TONIC-CLONIC SEIZURE 28
713 HAIR COLOUR CHANGES 28
714 MULTIPLE ORGAN DYSFUNCTION SYNDROME 28
715 NERVE COMPRESSION 28
716 NEUROTOXICITY 28
717 PELVIC FRACTURE 28
718 PERSONALITY CHANGE 28
719 STOMA SITE ODOUR 28
720 TASTE DISORDER 28
721 THROAT TIGHTNESS 28
722 APPLICATION SITE BURN 27
723 BRADYPHRENIA 27
724 DYSGRAPHIA 27
725 ELECTROCARDIOGRAM QT PROLONGED 27
726 FULL BLOOD COUNT DECREASED 27
727 INTERNATIONAL NORMALISED RATIO INCREASED 27
728 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27
729 MALIGNANT NEOPLASM PROGRESSION 27
730 PAIN IN JAW 27
731 SHOCK 27
732 SMALL INTESTINAL OBSTRUCTION 27
733 STOMA COMPLICATION 27
734 TACHYPNOEA 27
735 THIRST 27
736 TOOTH LOSS 27
737 VISUAL ACUITY REDUCED 27
738 BLOOD POTASSIUM INCREASED 26
739 BLOOD UREA INCREASED 26
740 DERMATITIS ATOPIC 26
741 DRUG DOSE TITRATION NOT PERFORMED 26
742 EAR INFECTION 26
743 ERUCTATION 26
744 FAECALOMA 26
745 FLUID OVERLOAD 26
746 HYPERTENSIVE CRISIS 26
747 INFUSION SITE BRUISING 26
748 MUSCULOSKELETAL DISCOMFORT 26
749 MYOCLONUS 26
750 ORTHOSTATIC INTOLERANCE 26
751 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 26
752 SUBDURAL HAEMATOMA 26
753 TREATMENT FAILURE 26
754 TROPONIN INCREASED 26
755 UROSEPSIS 26
756 BINGE EATING 25
757 CARDIOMEGALY 25
758 CLAVICLE FRACTURE 25
759 CORONARY ARTERY OCCLUSION 25
760 DERMATITIS 25
761 DEVICE DELIVERY SYSTEM ISSUE 25
762 EYE SWELLING 25
763 GASTROENTERITIS VIRAL 25
764 GLYCOSYLATED HAEMOGLOBIN INCREASED 25
765 HEMIPARESIS 25
766 ILLUSION 25
767 IRON DEFICIENCY ANAEMIA 25
768 JAUNDICE 25
769 MASS 25
770 ORAL DISCOMFORT 25
771 PRE-EXISTING CONDITION IMPROVED 25
772 PRURITUS GENERALISED 25
773 SINUS CONGESTION 25
774 SKIN INFECTION 25
775 SLEEP DEFICIT 25
776 SUSPECTED SUICIDE 25
777 TOOTH EXTRACTION 25
778 TORSADE DE POINTES 25
779 ADVERSE REACTION 24
780 AFFECTIVE DISORDER 24
781 BACK INJURY 24
782 BLOOD GLUCOSE ABNORMAL 24
783 DEAFNESS 24
784 JOINT RANGE OF MOTION DECREASED 24
785 OBESITY 24
786 SEXUALLY INAPPROPRIATE BEHAVIOUR 24
787 VITAMIN B12 DEFICIENCY 24
788 VOLVULUS 24
789 ABDOMINAL PAIN LOWER 23
790 ACNE 23
791 AKATHISIA 23
792 APHONIA 23
793 BLOOD MAGNESIUM DECREASED 23
794 BURSITIS 23
795 CEREBRAL DISORDER 23
796 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23
797 CYANOSIS 23
798 EAR PAIN 23
799 FORMICATION 23
800 GRIP STRENGTH DECREASED 23
801 HAIR TEXTURE ABNORMAL 23
802 HUMERUS FRACTURE 23
803 INFUSION SITE NODULE 23
804 LIVING IN RESIDENTIAL INSTITUTION 23
805 LYMPHADENOPATHY 23
806 MENISCUS INJURY 23
807 MITRAL VALVE INCOMPETENCE 23
808 MULTIPLE FRACTURES 23
809 PARAESTHESIA ORAL 23
810 PHOTOPHOBIA 23
811 POTENTIATING DRUG INTERACTION 23
812 PULMONARY THROMBOSIS 23
813 SCAR 23
814 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 23
815 SPINAL DISORDER 23
816 THYROID DISORDER 23
817 TOOTH INFECTION 23
818 ASPHYXIA 22
819 ATRIAL FLUTTER 22
820 ATRIOVENTRICULAR BLOCK FIRST DEGREE 22
821 BEZOAR 22
822 CERVICAL VERTEBRAL FRACTURE 22
823 DYSPHEMIA 22
824 FEBRILE NEUTROPENIA 22
825 FRUSTRATION TOLERANCE DECREASED 22
826 HYSTERECTOMY 22
827 ISCHAEMIC STROKE 22
828 MAJOR DEPRESSION 22
829 MICTURITION DISORDER 22
830 OBSESSIVE THOUGHTS 22
831 PARKINSONIAN CRISIS 22
832 PHOTOPSIA 22
833 SARS-COV-2 TEST POSITIVE 22
834 SPINAL PAIN 22
835 STEVENS-JOHNSON SYNDROME 22
836 VITAMIN D DEFICIENCY 22
837 WOUND INFECTION 22
838 APPETITE DISORDER 21
839 BODY TEMPERATURE INCREASED 21
840 BONE DENSITY DECREASED 21
841 CONCUSSION 21
842 DRUG DOSE OMISSION BY DEVICE 21
843 DRUG-INDUCED LIVER INJURY 21
844 EXERCISE TOLERANCE DECREASED 21
845 HAIR DISORDER 21
846 HYPERPHAGIA 21
847 INFUSION SITE INFECTION 21
848 MALABSORPTION 21
849 MYDRIASIS 21
850 MYOCARDIAL ISCHAEMIA 21
851 NEUROPROSTHESIS IMPLANTATION 21
852 ORAL MUCOSAL BLISTERING 21
853 PANIC REACTION 21
854 PRODUCT PACKAGING ISSUE 21
855 SCOLIOSIS 21
856 SKIN MASS 21
857 STRESS CARDIOMYOPATHY 21
858 UNINTENTIONAL MEDICAL DEVICE REMOVAL 21
859 AORTIC ANEURYSM 20
860 APPLICATION SITE DERMATITIS 20
861 BLOOD LACTATE DEHYDROGENASE INCREASED 20
862 BLOOD PRESSURE DIASTOLIC DECREASED 20
863 CEREBRAL ATROPHY 20
864 COLON CANCER 20
865 COMMUNICATION DISORDER 20
866 CYST 20
867 DENTAL CARIES 20
868 ELECTROLYTE IMBALANCE 20
869 EXOSTOSIS 20
870 HYPERLIPIDAEMIA 20
871 HYPERTHERMIA 20
872 HYPOTONIA 20
873 IRRITABLE BOWEL SYNDROME 20
874 MUSCLE ATROPHY 20
875 PANCREATIC CARCINOMA 20
876 PLEUROTHOTONUS 20
877 PULMONARY ARTERIAL HYPERTENSION 20
878 REBOUND EFFECT 20
879 SCAB 20
880 SINUS TACHYCARDIA 20
881 SNEEZING 20
882 SNORING 20
883 TERMINAL INSOMNIA 20
884 VITREOUS FLOATERS 20
885 BACTERIAL INFECTION 19
886 BONE DISORDER 19
887 CARDIAC MURMUR 19
888 COAGULOPATHY 19
889 DEVICE DEFECTIVE 19
890 DEVICE PLACEMENT ISSUE 19
891 DRUG EFFECT VARIABLE 19
892 DRUG PRESCRIBING ERROR 19
893 ENTERAL NUTRITION 19
894 GROIN PAIN 19
895 HUNGER 19
896 HYPERVENTILATION 19
897 HYPOAESTHESIA ORAL 19
898 INCORRECT DRUG ADMINISTRATION DURATION 19
899 LUMBAR VERTEBRAL FRACTURE 19
900 LYMPHOMA 19
901 MEDICAL DEVICE DISCOMFORT 19
902 MEDICAL DEVICE PAIN 19
903 METASTASES TO LIVER 19
904 MUSCLE STRAIN 19
905 MUSCULOSKELETAL CHEST PAIN 19
906 ORAL CANDIDIASIS 19
907 ORAL HERPES 19
908 PANIC DISORDER 19
909 PLASMA CELL MYELOMA 19
910 PULMONARY MASS 19
911 RASH PAPULAR 19
912 SKIN SWELLING 19
913 SYSTEMIC LUPUS ERYTHEMATOSUS 19
914 TOOTHACHE 19
915 TRANSAMINASES INCREASED 19
916 TRANSFUSION 19
917 WEIGHT ABNORMAL 19
918 ABDOMINAL RIGIDITY 18
919 ABSCESS 18
920 ARTHRITIS INFECTIVE 18
921 BASAL CELL CARCINOMA 18
922 BLOOD PRESSURE SYSTOLIC INCREASED 18
923 CATARACT OPERATION 18
924 CHOLECYSTECTOMY 18
925 DEVICE EXPULSION 18
926 DIALYSIS 18
927 EYE PRURITUS 18
928 GASTRIC HAEMORRHAGE 18
929 GASTROINTESTINAL HYPOMOTILITY 18
930 GASTROINTESTINAL INFECTION 18
931 HEPATIC CIRRHOSIS 18
932 IMPAIRED WORK ABILITY 18
933 LIVER FUNCTION TEST ABNORMAL 18
934 MACULAR DEGENERATION 18
935 METABOLIC ENCEPHALOPATHY 18
936 OSTEONECROSIS 18
937 OXYGEN SATURATION ABNORMAL 18
938 PAROSMIA 18
939 PNEUMONITIS 18
940 PNEUMOTHORAX 18
941 POST-TRAUMATIC STRESS DISORDER 18
942 PRODUCT COMPLAINT 18
943 PRODUCT INEFFECTIVE 18
944 SOCIAL AVOIDANT BEHAVIOUR 18
945 STOMA SITE INDURATION 18
946 TENDON RUPTURE 18
947 TENDONITIS 18
948 THERAPY CHANGE 18
949 ARTHROPOD BITE 17
950 ASCITES 17
951 BLINDNESS UNILATERAL 17
952 COMPULSIVE SEXUAL BEHAVIOUR 17
953 DAYDREAMING 17
954 DEPRESSIVE SYMPTOM 17
955 DIABETIC NEUROPATHY 17
956 DUODENAL ULCER 17
957 ENURESIS 17
958 EXTRASYSTOLES 17
959 FACE INJURY 17
960 FOOD CRAVING 17
961 GENERALISED OEDEMA 17
962 GLOSSODYNIA 17
963 HAEMODYNAMIC INSTABILITY 17
964 HAEMORRHAGIC ANAEMIA 17
965 HEMIPLEGIA 17
966 INFUSION SITE CELLULITIS 17
967 INFUSION SITE INFLAMMATION 17
968 INTENTIONAL SELF-INJURY 17
969 LIVER FUNCTION TEST INCREASED 17
970 LOWER GASTROINTESTINAL HAEMORRHAGE 17
971 MADAROSIS 17
972 MYASTHENIA GRAVIS 17
973 MYOPATHY 17
974 NEEDLE ISSUE 17
975 OVERWEIGHT 17
976 PETIT MAL EPILEPSY 17
977 PHARYNGEAL OEDEMA 17
978 PHARYNGEAL SWELLING 17
979 PHARYNGITIS STREPTOCOCCAL 17
980 PNEUMOPERITONEUM 17
981 PROSTATIC SPECIFIC ANTIGEN INCREASED 17
982 PROTEINURIA 17
983 RESPIRATORY TRACT CONGESTION 17
984 SCRATCH 17
985 SINUS BRADYCARDIA 17
986 SKIN FISSURES 17
987 SKIN HAEMORRHAGE 17
988 ABNORMAL LOSS OF WEIGHT 16
989 ANAPHYLACTIC SHOCK 16
990 AUTONOMIC NERVOUS SYSTEM IMBALANCE 16
991 BLADDER CATHETERISATION 16
992 BLOOD URIC ACID INCREASED 16
993 BRAIN NEOPLASM 16
994 BREAST PAIN 16
995 CATHETER SITE BRUISE 16
996 CATHETER SITE ERYTHEMA 16
997 CATHETER SITE PAIN 16
998 CHOLECYSTITIS 16
999 COMA SCALE ABNORMAL 16